title: Successful treatment of alopecia areata with Dr. Michaels® (Alopinex) product family.
abstract: Alopecia areata is a highly prevalent organ restricted autoimmune disorder that leads to disfiguring hair loss and is thought to involve a T cellmediated response to the hair follicle. The treatment of alopecia areata is often problematic and very frustrating, partly due to the unknown aetiology of the condition. The aim of this study was to evaluate the efficacy and tolerability of complementary medicine, Dr. Michaels® product family, in the treatment of alopecia areata.
  
  
  
  40 patients (27 female/13 male), with a mean age of 20.3 years, all of them with 1-3 lesions of stable alopecia areata localized on the scalp were included in this trial. Four patients suffered from Hashimoto thyroiditis, and one had a familial history of LES. Exclusion criteria were the use of any treatment or medication, which may influence or interfere with the course of the disease. All patients were treated with Dr. Michaels® StimOils - applied twice daily (morning and night), Hair Lotion  applied twice daily (morning and night), and oral herbal formulation - PSC 900 2ml twice daily with food for 16 weeks. For each patient, photographs of typical lesions were taken at the beginning and at 4, 8, 12 and 16 weeks follow-up. Patient improvement was determined by the percentage of hair regrowth for each lesion.
  
  
  
  After 10 weeks of treatment using StimOils, Hair Lotion and PSC 900 from Dr. Michaels® product family, 18 patients had achieved an excellent response with regrowth in all the affected alopecia areata patches. 17 patients achieved the same results after 12 weeks of treatment; the other 5 patients had to continue the therapeutic protocol for another 2-3 weeks.
  
  
  
  This study demonstrates that the Dr. Michaels® StimOils, Hair Lotion and PSC 900 are an effective therapeutic option for the treatment of alopecia areata. This has important implications for resistant cases of alopecia areata where traditional systemic and topical corticosteroid therapies have failed. In addition, this treatment approach may be an attractive option for patients who have growing concern regarding side-effects of long-term corticosteroid therapy.
authors: Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany.
authors: U
authors: U
authors: Wollina
authors: 2nd Medical Faculty, Charles University, Bulovka Hospital, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
authors: J
authors: J
authors: Hercogovấ
authors: Department of Nuclear Physics, Sub-nuclear and Radiation, G. Marconi University, Rome, Italy.
authors: M
authors: M
authors: Fioranelli
authors: Dermatological Department University of Pisa, Pisa, Italy.
authors: S
authors: S
authors: Gianfaldoni
authors: Onkoderma-Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria; Department of Dermatology and Venereology, Medical University of Plovdiv, Medical faculty, Plovdiv, Bulgaria.
authors: A A
authors: AA
authors: Chokoeva
authors: Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria.
authors: G
authors: G
authors: Tchernev
authors: Psoriasis and Skin Clinic, Melbourne, Australia.
authors: M
authors: M
authors: Tirant
authors: PRO SANUM Ltd, Sanatorium of Prof. Novotný, Štěpánská Prague 1, Czech Republic.
authors: F
authors: F
authors: Novotny
authors: University B.I.S. Group of Institutions, Punjab Technical University, Punjab, India.
authors: M G
authors: MG
authors: Roccia
authors: Department Medicinal Information and Non-interventional studies, Bulgarian Drug Agency Sofia, Bulgaria.
authors: G K
authors: GK
authors: Maximov
authors: Department of Dermatology and Cutaneous Surgery, Department of Psychiatry and Behavioral Sciences, Institute for Bioethics and Health Policy, University of Miami, Miller School of Medicine, Miami, FL, USA; Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Università Degli Studi "G. Marconi", Rome, Italy.
authors: K
authors: K
authors: França
authors: Chair of Dermatology, University of Rome G. Marconi Rome, Italy.
authors: T
authors: T
authors: Lotti
mesh_terms: D000506:Alopecia Areata / Q000150:complications / Q000628:therapy*; D000529:Complementary Therapies / Q000379:methods*; D005260:Female; D006197:Hair / Q000187:drug effects*; D050031:Hashimoto Disease / Q000150:complications; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D055815:Young Adult